nephSAP: Volume 17
130
6.1MB
The quest to define the lower limits and perfusion requirements of the human kidney has never been more challenging.
→
Volume 17, Number 1, March 2018
Hypertension
Debbie L. Cohen, MD, Karen A. Griffin, MD
AMA PRA Category 1 Credits™
The quest to define the lower limits and perfusion requirements of the human kidney has never been more challenging....
101
3.3MB
This issue of NephSAP is dedicated to interventional nephrology. This discipline was a nascent field in 2003 when all 18 ESRD Networks and the Centers for Medicare and Medicaid Services (CMS), together with clinicians, dialysis providers, and patients, de
→
Volume 17, Number 2, June 2018
Interventional Nephrology and Dialysis Access
Anil K. Agarwal MD, Lalathaksha Murthy Kumbar MD and Vandana Dua Niyyar MD
AMA PRA Category 1 Credits™
This issue of NephSAP is dedicated to interventional nephrology. This discipline was a nascent field in 2003 when all 18 ESRD Networks and the Centers for Medicare and Medicaid Services (CMS), together with clinicians, dialysis providers, and patients, de...
70
3.8MB
Since the early 2000s, investigators have been studying the regulation and effects of elevated fibroblast growth factor 23 (FGF23) levels in the setting of CKD.
→
Volume 17, Number 3, August 2018
Disorders of Divalent Ions, Renal Bone Disease and Nephrolithiasis
Stanley Goldfarb, MD and Kevin J. Martin, MBBCh
AMA PRA Category 1 Credits™
Since the early 2000s, investigators have been studying the regulation and effects of elevated fibroblast growth factor 23 (FGF23) levels in the setting of CKD....
80
1.4MB
Focal segmental glomerulosclerosis (FSGS) and collapsing glomerulopathy (CG) are distinct clinical pathologic syndromes that are associated with podocyte injury and podocyte precursor dysfunction, respectively.
→
Volume 17, Number 4, September 2018
Secondary Glomerular Diseases
Brad H. Rovin, MD
AMA PRA Category 1 Credits™
Focal segmental glomerulosclerosis (FSGS) and collapsing glomerulopathy (CG) are distinct clinical pathologic syndromes that are associated with podocyte injury and podocyte precursor dysfunction, respectively....
80
9MB
This issue of NephSAP on end-stage renal disease (ESRD) and dialysis discusses the most recent survival data and, importantly, examines other traditional and nontraditional clinical outcomes, including quality of life (QoL), cognition, cardiovascular dise
→
Volume 17, Number 5, November 2018
End-Stage Renal Disease and Dialysis
Ruediger W. Lehrich, MD and John P. Middleton, MD
AMA PRA Category 1 Credits™
This issue of NephSAP on end-stage renal disease (ESRD) and dialysis discusses the most recent survival data and, importantly, examines other traditional and nontraditional clinical outcomes, including quality of life (QoL), cognition, cardiovascular dise...